The core activity of Allergopharma AG is the diagnosis and treatment of Type I allergies, particularly through subcutaneous immunotherapy (SCIT) and the development of high-dose, hypoallergenic preparations (allergoids) as well as allergens for diagnostic purposes.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.